Minerva Neurosciences, Inc.
Minerva Neurosciences, Inc. (NERV) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · NERV · as of Sep 30, 2025
Ownership Breakdown
22
Institutional Holders
▲ 4 vs Q2
$4.21M
Total Inst. Value
▲ $866,766 vs Q2
6.99M
Shares Outstanding
freeFloat 75.93%
1.98M
13F Shares Held
▲ 35,209 vs Q2
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
NERV largest shareholders · institutional ownership
Q3 2025 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
FEDERATED HERMES, INC. pharmaceutical preparations | 1.35M | 17.85% | 17.85% | $2.86B | Nov 3, 2025 | — held |
VANGUARD GROUP INC pharmaceutical preparations | 252.0K | 3.33% | 3.33% | $534.30M | Nov 7, 2025 | ▼ 31 |
RENAISSANCE TECHNOLOGIES LLC pharmaceutical preparations | 116.5K | 1.54% | 1.54% | $245.23M | Nov 13, 2025 | ▲ 5.5K |
GEODE CAPITAL MANAGEMENT, LLC pharmaceutical preparations | 75.6K | 99.91% | 99.91% | $160.36M | Nov 12, 2025 | — held |
BLACKROCK, INC. pharmaceutical preparations | 72.7K | 96.01% | 96.01% | $152.97M | Nov 12, 2025 | — held |
APELLA CAPITAL, LLC pharmaceutical preparations | 39.3K | 51.94% | 51.94% | $99.48M | Oct 17, 2025 | ▲ 18.4K |
ACADIAN ASSET MANAGEMENT LLC pharmaceutical preparations | 17.4K | 23.01% | 23.01% | $36.00M | Nov 13, 2025 | — held |
STATE STREET CORP pharmaceutical preparations | 16.5K | 21.82% | 21.82% | $35.02M | Nov 14, 2025 | — held |
ADAR1 CAPITAL MANAGEMENT, LLC pharmaceutical preparations | 12.4K | 16.39% | 16.39% | $26.11M | Nov 14, 2025 | — held |
MORGAN STANLEY pharmaceutical preparations | 11.0K | 14.54% | 14.54% | $23.17M | May 27, 2026 | — held |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q3 2025 vs prior quarter
Q3 2025
2
Increased
+23.9K shares6
New Positions
first time holders4
Decreased
−1.8K shares2
Sold Out
fully exitedNet shares change (top 50)
+22.1K
+23.9K / −1.8K
Net new holders
+2
6 new / 2 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
NERV insider trading · insider activity
Source: SEC Form 4
8
Buy transactions
0
Sell transactions
0.00
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Ahlholm Frederick W SVP, CFO and Secretary | Jun 3, 2026 | Award | 680,000 | $4.68 | $3.18M | 680.0K | Form 4 ↗ |
Luthringer Remy CEO | Jun 3, 2026 | Award | 1,690,700 | $4.68 | $7.91M | 1.69M | Form 4 ↗ |
Laghrissi-Thode Fouzia director | Jun 3, 2026 | Award | 50,000 | $4.68 | $234.0K | 50.0K | Form 4 ↗ |
Kupfer David director | Jun 3, 2026 | Award | 50,000 | $4.68 | $234.0K | 50.0K | Form 4 ↗ |
Kaul Inderjit director | Jun 3, 2026 | Award | 50,000 | $4.68 | $234.0K | 50.0K | Form 4 ↗ |
VAN HEEK G JAN director | Jun 3, 2026 | Award | 50,000 | $4.68 | $234.0K | 50.0K | Form 4 ↗ |
HASLER HANS PETER director | Jun 3, 2026 | Award | 50,000 | $4.68 | $234.0K | 50.0K | Form 4 ↗ |
O'Connor James Joseph Chief Business Officer and GC | Apr 21, 2026 | Award | 350,800 | $6.97 | $2.45M | 350.8K | Form 4 ↗ |
Kaul Inderjit director | Mar 31, 2026 | Award | 12,169 | $6.03 | $73.4K | 12.2K | Form 4 ↗ |
Kupfer David director | Dec 22, 2025 | Award | 50,000 | $3.98 | $199.0K | 50.0K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Minerva Neurosciences, Inc. (NERV) is primarily owned by institutional investors, who hold approximately 28.3% of total shares outstanding. Company insiders own approximately 24.07%, while retail and public investors account for the remaining 47.62%.
The largest institutional shareholder of Minerva Neurosciences, Inc. is FEDERATED HERMES, INC., holding approximately 1.35 million shares — equal to 17.85% of outstanding shares — as of September 30, 2025.
A total of 22 institutional investors currently hold NERV stock, with a combined institutional value of approximately $4,208,645 as of the most recent 13F filing period.
Frequently asked questions
NERV ownershipMinerva Neurosciences, Inc. (NERV) is primarily owned by institutional investors, who hold approximately 28.3% of shares. The largest shareholder is FEDERATED HERMES, INC. with a 17.85% stake. Company insiders hold 24.07%. Data sourced from SEC Form 13F as of September 30, 2025.